Retina-based paraneoplastic syndromes involving the visual system are relatively rare, but easy to overlook.

Fortunately, endophthalmitis after intravitreal injection is rare, but clinicians should maintain a low threshold for treatment.

A look at the distinct clinical features that help to establish the diagnosis and guide treatment of these malignancies.

Novel approaches include antioxidant therapy, protecting photoreceptors and RPE and suppressing inflammation.

Drugs that combine regression of CNV with resolution of permeability in wet AMD may enhance visual outcomes.

Despite encouraging findings, it's too early to call for broad adoption of anti-VEGF therapy for retinopathy of prematurity.

Gene therapy for ophthalmic disease may offer significant benefits to patients in safety, efficacy and convenience.

Diagnosis and treatment of uveal melanoma have advanced significantly, but questions and challenges remain.

Microincision vitrectomy allows for efficient surgery, fast recovery, reduced inflammation and good visual outcomes.

Management of retained intraocular lens fragments plays a great role in determining the final visual acuity.